Chardonnay By-Product May Improve Cardiovascular Health

Why It Matters

Post‑prandial triglyceride spikes are a stronger predictor of cardiovascular events than fasting levels, so a natural, waste‑derived supplement that blunts this response could become a cost‑effective tool for ASCVD risk management.

Key Takeaways

• High Chardonnay marc blend reduced post‑prandial triglyceride response
• Modest increase in HDL‑C observed alongside triglyceride reduction
• Whole‑food marc outperformed isolated seed extract in trial
• Study involved 24 mildly dyslipidemic adults over 16 weeks
• Marc utilizes agricultural waste, adding sustainability to cardiovascular health

Pulse Analysis

The growing interest in polyphenol‑rich grape by‑products has traditionally focused on red‑wine extracts such as resveratrol. Chardonnay marc, the skins and seeds left after white‑wine pressing, retains a broader spectrum of nutrients—including fiber, flavonoids, and non‑extractable phenolics—that are often discarded. By repurposing this agricultural waste, researchers tap into a sustainable source of bioactive compounds that could complement existing dietary strategies for heart health.

In the UC Davis‑led double‑blind crossover trial, 24 participants with mild dyslipidemia consumed 1,500 mg daily of either a high‑marc blend, a high‑seed‑extract blend, or placebo for three weeks per phase. The marc group experienced a statistically significant attenuation of post‑prandial triglyceride spikes, a metric increasingly recognized as a more accurate predictor of atherosclerotic events than fasting lipids. While fasting triglycerides showed a non‑significant downward trend, the rise in HDL‑C further suggests an overall improvement in lipid balance. The findings highlight the importance of the whole‑food matrix, where synergistic interactions among compounds may drive health benefits beyond isolated extracts.

For the nutraceutical market, these results open a pathway to develop value‑added products from what was once waste, aligning profitability with environmental stewardship. Companies can position Chardonnay marc supplements as a natural, evidence‑backed option for consumers seeking to manage post‑meal lipid spikes without prescription drugs. However, larger, longer‑term studies are needed to confirm cardiovascular outcomes and to determine optimal dosing. If validated, marc‑based formulations could reshape preventive cardiology, offering a low‑cost, sustainable adjunct to lifestyle and pharmacologic interventions.